Please login to the form below

Not currently logged in
Email:
Password:

EADV congress

This page shows the latest EADV congress news and features for those working in and with pharma, biotech and healthcare.

New data keeps AbbVie’s star pipeline therapies on track

New data keeps AbbVie’s star pipeline therapies on track

At the European Academy of Dermatology and Venereology (EADV) Congress in Paris this week, the company reported outcomes data from three studies of its interleukin-23 inhibitor risankizumab in psoriasis – firming ... Lilly reported positive phase II

Latest news

  • Novartis' secukinumab has 'consistent' activity in psoriasis Novartis' secukinumab has 'consistent' activity in psoriasis

    The data - which was presented at the European Association of Dermatology and Venereology (EADV) Congress in Amsterdam this week - reinforces earlier studies suggesting that secukinumab was more effective in treating psoriasis ... Novartis reported

  • Trial success for Novartis' psoriasis drug

    Novartis has presented data at the European Academy of Dermatology and Venereology Congress that demonstrates investigational psoriasis treatment AIN457 is effective in up to 81 per cent of patients. ... Novartis has presented data at the European

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics